Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
Open claims and closed payer claims data are essential for understanding the status and activities...
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic inflammatory disease affecting roughly 2-3% of U.S. adults (over 7.5 million people) making it one of the most prevalent immune-mediated conditions in the coun...